前收市價 | 25.60 |
開市 | 25.60 |
買盤 | 24.80 |
賣出價 | 26.40 |
拍板 | 195.00 |
到期日 | 2026-01-16 |
今日波幅 | 25.60 - 25.60 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 7 |
FDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use of AbbVie's (ABBV) Skyrizi and AstraZeneca's (AZN) Imfinzi.
The power of compounding can build huge amounts of passive income.
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes? Let's find out.